Barclays’s VIROPHARMA INC VPHM Stock Holding History

Barclays’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-700	Closed	-$34K	–	7959
2013 Q4	$34K	Sell	700 -249,200	-100%	-$11.1M	﹤0.01%	6442
2013 Q3	$9.75M	Buy	249,900 +248,300	+15,519%	+$8.12M	0.01%	1162
2013 Q2	$46K	Buy	+1,600	New	+$42.2K	﹤0.01%	6372

Barclays's VPHM Position: Q1 2014 in Review

Barclays sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 910,864 shares — an estimated $44.6M sold.

Barclays first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $44.6M in Q4 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

Barclays reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
Barclays sold 910,864 VIROPHARMA INC shares in Q1 2014, an estimated $44.6M.
Barclays first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
Barclays's VIROPHARMA INC position peaked at $44.6M in Q4 2013.
0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.